Abstract
BackgroundThere is great interest in developing new treatment approaches for systemic lupus erythematosus (SLE), but the biologic therapies under investigation have yielded disappointing results. Recently the nuclear export protein XPO1...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have